Ann

Mercury Broadband Opens New Ann Arbor Area Service Center in Saline, Michigan

Retrieved on: 
Wednesday, January 4, 2023

MISSION, Kan., Jan. 4, 2023 /PRNewswire-PRWeb/ -- Garrett Wiseman, Co-Founder and Chief Executive of Mercury Broadband announced today the official opening of the company's new Ann Arbor area Service Center located at 1300 Tefft Ct., Suite 1, Saline, Michigan. Mercury Broadband currently provides reliable High Speed Internet services to homes and businesses in the rural and surrounding areas across Washtenaw County and will also expand into the counties of Hillsdale, Lenawee, Monroe, Jackson, Wayne, Ingham, and Livingston. Justin Girardot has been named the General Manager and leads the company's efforts in this new Service Center region.

Key Points: 
  • MISSION, Kan., Jan. 4, 2023 /PRNewswire-PRWeb/ -- Garrett Wiseman, Co-Founder and Chief Executive of Mercury Broadband announced today the official opening of the company's new Ann Arbor area Service Center located at 1300 Tefft Ct., Suite 1, Saline, Michigan.
  • Justin Girardot has been named the General Manager and leads the company's efforts in this new Service Center region.
  • "We are very excited to officially open our new Ann Arbor area Service Center and expand our broadband services to the Ann Arbor/Jackson areas", said Mr. Wiseman.
  • Mercury Broadband has actually already been providing services in the Ann Arbor area for several months as part of a limited market trial and testing process.

The Nation's Only Boarding School Obesity Program Boasts Outcomes Rivaling Bariatric Surgery

Retrieved on: 
Tuesday, December 27, 2022

PHOENIX, Dec. 27, 2022 /PRNewswire-PRWeb/ -- A research study presented at Obesity Week in San Diego in November has raised some eyebrows in the obesity research and treatment community. Obesity Week is an international research conference sponsored by The Obesity Society in which the best and brightest minds converge to discuss the latest breakthroughs in treatment of obesity as a chronic metabolic condition. The research study was co-authored by pediatric obesity experts from the University of Minnesota, Arizona State University and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK , a division of the National Institutes of Health). The abstract highlighted the outcomes of a residential obesity treatment program named Gem Academy.

Key Points: 
  • A revolutionary residential program in Arizona for treating teens with severe weight issues has outcomes that are better than bariatric surgery.
  • Obesity Week is an international research conference sponsored by The Obesity Society in which the best and brightest minds converge to discuss the latest breakthroughs in treatment of obesity as a chronic metabolic condition.
  • The abstract highlighted the outcomes of a residential obesity treatment program named Gem Academy.
  • Gem Academy (Phoenix, AZ) has, in the last 4 years produced outcomes in treating adolescent obesity in teen girls that has had tremendous efficacy.

The University of San Francisco Receives $15 Million from the Ann and Gordon Getty Foundation for the Arts

Retrieved on: 
Friday, December 23, 2022

SAN FRANCISCO, Dec. 22, 2022 /PRNewswire-PRWeb/ -- The University of San Francisco (USF) has received a gift of $15 million from the Ann and Gordon Getty Foundation for the Arts from the auction of more than 1,500 of their collected artworks. Gordon Getty '56 and his late wife, Ann Getty, shared a passion for the arts, and this gift will build a foundation to help create the Ann Getty Institute of Art and Design at USF.

Key Points: 
  • The University of San Francisco has received $15 million from the Ann and Gordon Getty Foundation for the Arts, which will help create the Ann Getty Institute of Art and Design at USF.
  • SAN FRANCISCO, Dec. 22, 2022 /PRNewswire-PRWeb/ -- The University of San Francisco (USF) has received a gift of $15 million from the Ann and Gordon Getty Foundation for the Arts from the auction of more than 1,500 of their collected artworks.
  • Gordon Getty '56 and his late wife, Ann Getty, shared a passion for the arts, and this gift will build a foundation to help create the Ann Getty Institute of Art and Design at USF.
  • The University of San Francisco is a private, Jesuit Catholic university that reflects the diversity, optimism, and opportunities of the city that surrounds it.

Phoenix Children's Launches Division of Anesthesiology, Names Leadership Team

Retrieved on: 
Tuesday, December 20, 2022

PHOENIX, Dec. 20, 2022 /PRNewswire/ -- Phoenix Children's, one of the nation's fastest-growing pediatric health systems, has announced the creation of a new Division of Anesthesiology and named Dr. Narasimhan "Sim" Jagannathan as Division Chief and Dr. Amod Sawardekar as Associate Division Chief.

Key Points: 
  • PHOENIX, Dec. 20, 2022 /PRNewswire/ -- Phoenix Children's , one of the nation's fastest-growing pediatric health systems, has announced the creation of a new Division of Anesthesiology and named Dr. Narasimhan "Sim" Jagannathan as Division Chief and Dr. Amod Sawardekar as Associate Division Chief.
  • Joining the newly created Division of Anesthesiology are 39 experienced providers who recently transitioned from a longstanding private practice into Phoenix Children's Medical Group.
  • This team is already an integral part of daily care delivery, having practiced extensively within Phoenix Children's health system.
  • In addition to the Division of Anesthesia, Phoenix Children's recently created a Division of Infectious Diseases and a Division of Nephrology and announced leadership appointments in each.

Childhood Brain Tumor Expert Joins Hassenfeld Children's Hospital at NYU Langone as Director of Pediatric Neuro-Oncology

Retrieved on: 
Tuesday, December 20, 2022

Prior to Hassenfeld Children's Hospital, Dr. Clymer was a clinician at Dana-Farber/Boston Children's Cancer and Blood Disorders Center.

Key Points: 
  • Prior to Hassenfeld Children's Hospital, Dr. Clymer was a clinician at Dana-Farber/Boston Children's Cancer and Blood Disorders Center.
  • She was also an instructor in the Department of Pediatrics and director of the Neuro-Oncology Fellowship at Harvard Medical School.
  • Hassenfeld Children's Hospital offers the latest technologies and early clinical trials, expanding overall treatment options and patient success rates.
  • She went on to complete a fellowship in pediatric hematology/oncology at Ann and Robert M. Lurie Children's Hospital of Chicago and a pediatric neuro-oncology fellowship within Dana-Farber Cancer Institute and Boston Children's Hospital.

Stoke Therapeutics Presents Data from a Combined Interim Analysis of the Phase 1/2a MONARCH and ADMIRAL Studies of STK-001 in Children and Adolescents with Dravet Syndrome at the American Epilepsy Society (AES) 2022 Annual Meeting

Retrieved on: 
Friday, December 2, 2022

A total of seven posters will be presented at the American Epilepsy Society (AES) 2022 Annual Meeting, December 2-6.

Key Points: 
  • A total of seven posters will be presented at the American Epilepsy Society (AES) 2022 Annual Meeting, December 2-6.
  • Dravet syndrome is a severe and progressive genetic epilepsy characterized by frequent, prolonged and refractory seizures beginning within the first year of life.
  • STK-001 represents an entirely new approach to treatment, one that aims to treat the syndrome, not just the seizures.
  • Topline data from a combined interim analysis of the Phase 1/2a MONARCH and ADMIRAL studies showed single and multiple doses of STK-001 up to 45mg were well-tolerated.

Stoke Therapeutics to Present Data from the Company’s Dravet Syndrome Program at the American Epilepsy Society 2022 Annual Meeting

Retrieved on: 
Tuesday, November 29, 2022

The company is advancing STK-001 as potentially the first medicine to treat the underlying cause of Dravet syndrome.

Key Points: 
  • The company is advancing STK-001 as potentially the first medicine to treat the underlying cause of Dravet syndrome.
  • Compared with the general epilepsy population, people living with Dravet syndrome have a higher risk of sudden unexpected death in epilepsy, or SUDEP.
  • STK-001 is an investigational new medicine for the treatment of Dravet syndrome currently being evaluated in ongoing clinical trials.
  • Stokes first compound, STK-001, is in clinical testing for the treatment of Dravet syndrome, a severe and progressive genetic epilepsy.

Medical Doctor in Chicago Launches Jamaican Coffee Company to "Give Back" to Those in Her Island Country Who Paved the Way for Her Success

Retrieved on: 
Thursday, November 3, 2022

CHICAGO, Nov. 3, 2022 /PRNewswire/ -- Dr. Shardae Heinisch, a local pediatric dermatology fellow, who credits her island country of Jamaica with investing in her future, today will celebrate the one-year anniversary of her Jamaican coffee company, Mellow Royale Café, by being the first to introduce sorrel-infused coffee -- something no other coffee company has achieved. Heinisch also will donate a portion of her proceeds to the Jamaican Dermatology Healthcare System.

Key Points: 
  • Heinisch also will donate a portion of her proceeds to the Jamaican Dermatology Healthcare System.
  • Her plan was to return to Jamaica to put her training to work.
  • "I entered the medical field out of a genuine love for people, which prompted my desire to always find ways to give back," said Heinisch.
  • My goal is to donate proceeds from my endeavors to pay it forward and help others in need."

NCCN Updates Recommendations for COVID-19 Vaccination with Information on Bivalent Vaccines, Children with Cancer, and Other Developments

Retrieved on: 
Thursday, September 22, 2022

PLYMOUTH MEETING, Pa., Sept. 22, 2022 /PRNewswire/ -- Today, the National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—released updated recommendations from the NCCN Advisory Committee on COVID-19 Vaccination and Pre-exposure Prophylaxis. This latest evidence-based, expert consensus-formulated summary on cancer and COVID-19 vaccination and prevention is available for free at NCCN.org/covid-19. Significant revisions include new recommendations for the recently-approved bivalent vaccines and advice on protecting children with cancer.

Key Points: 
  • This latest evidence-based, expert consensus-formulated summary on cancer and COVID-19 vaccination and prevention is available for free at NCCN.org/covid-19 .
  • Significant revisions include new recommendations for the recently-approved bivalent vaccines and advice on protecting children with cancer.
  • The NCCN Guidelines for Patients provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation .
  • Visit NCCN.org for more information and follow NCCN on Facebook @NCCNorg , Instagram @NCCNorg , and Twitter @NCCN .

Michigan Medicine Modernizes Digital Experience for Healthcare Consumers in Expansion with Loyal

Retrieved on: 
Wednesday, September 7, 2022

ATLANTA, Sept. 7, 2022 /PRNewswire/ -- Following the success of Michigan Medicine's chatbot during the COVID-19 pandemic, the Ann Arbor-based academic medical center has agreed to a three-year contract to expand its relationship with Loyal, the preferred digital health platform for the nation's leading health systems and hospitals.

Key Points: 
  • Michigan Medicine will soon expand its chatbot to answer consumer questions about locations and relevant providers, billing and payments, and long-term COVID support services.
  • This addition to Michigan Medicine's existing AI technology will more efficiently recognize consumers' intent, point them to answers and provide the information they need.
  • "Consumers today have different expectations of healthcare providers; they want a digital experience that's personalized and meets their immediate needs," said Chad Mallory, CEO of Loyal.
  • Michigan Medicine includes the top ranked U-M Medical School and University of Michigan Health, which includes the C.S.